SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-219749
Filing Date
2018-07-17
Accepted
2018-07-17 16:56:02
Documents
5
Period of Report
2018-07-17

Document Format Files

Seq Description Document Type Size
1 6-K d538241d6k.htm 6-K 9075
2 EX-99.1 d538241dex991.htm EX-99.1 12037
3 GRAPHIC g538241g19h10.jpg GRAPHIC 1860
4 GRAPHIC g538241g51g69.jpg GRAPHIC 3785
5 GRAPHIC g538241g91k25.jpg GRAPHIC 1796
  Complete submission text file 0001193125-18-219749.txt   32939
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 18956961
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1